Intravenous Amiodarone for acute heart rate control in the critically III patient with atrial tachyarrhythmias

American Journal of Cardiology

Volumn 81, Issue 5, 1998, Pages 594-598

  Clemo, Henry F ^a   Wood, Mark A ^b   Gilligan, David M ^b   Ellenbogen, Kenneth A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIGOXIN; DILTIAZEM; ESMOLOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

AGED; AMIODARONE; CRITICAL ILLNESS; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA;

EID: 0032032694     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00962-4     Document Type: Article

References (16)

1. Artucio H, Pereira M. Cardiac arrhythmias in critically ill patients: epidemiologic study. Crit Care Med 1990;18:1383-1388.
2. Heywood JT, Graham B, Marais GE, Jutzy KR. Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure. Am J Cardiol 1991;67:1150-1152.
3. Schwartz M, Michelson EL, Sawin HS, MacVaugh H. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias. Chest 1988;93:705-711.
4. Singh BH, Sarma JSM. Amiodarone and amiodarone derivatives. In: Singh BN, Dzau VJ, Vanhoutte PM, Woosley RL, eds. Cardiovascular Pharmacology and Therapeutics. New York: Churchill Livingstone, 1994:689-709.
5. Strasberg B, Arditti A, Sclarovsky S, Lewin RF, Buimouici B, Agmon J. Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response. Int J Cardiol 1985;7:47-58.
6. Cowan JC, Gardiner P, Reid DS, Newell DJ, Campbell RW. A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction. J Cardiovasc Pharmacol 1986;8:252-256.
7. Donovan KD, Power BM, Hockings BEF, Dobb CJ, Lee KY. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 1995;75:693-697.
8. Galve E, Rius T, Ballester R, Artaza MA, Arnau JM, Garçia-Dorado D, Soler-Soler J. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1996;27: 1079-1082.
9. Kumar A. Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. South Med J 1996;89:779-785.
10. Knaus WM, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification. Crit Care Med 1985;13:818-829.
11. Nayebpour M, Talajic M, Jing W, Nattel S. Autonomic modulation of the frequency-dependent actions of diltiazem on the atrioventricular node in anesthetized dogs. J Pharmacol Exp Ther 1990;253:353-361.
12. Goldman S. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. Am J Cardiol 1975;35: 651-655.
13. DiMarco JP. Ventricular rate control in atrial fibrillation. In: DiMarco JP, Prystowsky EN, eds. Atrial Arrhythmias: State of the Art. Armonk, NY: Futura, 1995:289-301.
14. Dias VC, Weir SJ, Ellenbogen KA. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter. Circulation 1992;86:1421-1428.
15. Pittet D, Thievent B, Wenzel RP, Li N, Auckenthaler R, Suter PM. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996;153:684-693.
16. Moscucci M, Bates ER. Cardiogenic shock. Cardiol Clin 1995;13:391-406.